The important inflammatory cytokine IL‐17 acts as double‐edged sword in anti‐tumor immunity and tumorigenesis, since IL‐17 also facilitated tumor angiogenesis and enhanced tumor immune evasion (Murugaiyan & Saha, 2009; Qian et al., 2017). The gene discussed is IL17A; the disease is neoplasm.